NDC 64764-171

Dexilant

Dexlansoprazole

Dexilant is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is Dexlansoprazole.

Product ID64764-171_46c355cb-10d1-4364-a4a8-891d97a7e88d
NDC64764-171
Product TypeHuman Prescription Drug
Proprietary NameDexilant
Generic NameDexlansoprazole
Dosage FormCapsule, Delayed Release
Route of AdministrationORAL
Marketing Start Date2010-04-12
Marketing CategoryNDA / NDA
Application NumberNDA022287
Labeler NameTakeda Pharmaceuticals America, Inc.
Substance NameDEXLANSOPRAZOLE
Active Ingredient Strength30 mg/1
Pharm ClassesProton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 64764-171-00

7 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-00)
Marketing Start Date2010-04-12
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 64764-171-01 [64764017101]

Dexilant CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA022287
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-12

NDC 64764-171-11 [64764017111]

Dexilant CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA022287
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-12

NDC 64764-171-19 [64764017119]

Dexilant CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA022287
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-12

NDC 64764-171-00 [64764017100]

Dexilant CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA022287
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-12

NDC 64764-171-03 [64764017103]

Dexilant CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA022287
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-12

NDC 64764-171-90 [64764017190]

Dexilant CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA022287
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-12

NDC 64764-171-30 [64764017130]

Dexilant CAPSULE, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA022287
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-04-12

Drug Details

Active Ingredients

IngredientStrength
DEXLANSOPRAZOLE30 mg/1

OpenFDA Data

SPL SET ID:9819f033-3bbe-442e-8e92-45fec77b237d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 833213
  • 902626
  • 833204
  • 902624
    • UPC Code
  • 0364764175306
  • 0364764171308

    • Pharmacological Class

    • Proton Pump Inhibitor [EPC]
    • Proton Pump Inhibitors [MoA]
    • Proton Pump Inhibitor [EPC]
    • Proton Pump Inhibitors [MoA]

    Medicade Reported Pricing

    64764017130 DEXILANT DR 30 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Dexilant" or generic name "Dexlansoprazole"

    NDCBrand NameGeneric Name
    50090-4374Dexilantdexlansoprazole
    55154-5154Dexilantdexlansoprazole
    64764-171Dexilantdexlansoprazole
    64764-175Dexilantdexlansoprazole
    24979-001Dexlansoprazoledexlansoprazole
    24979-002Dexlansoprazoledexlansoprazole
    24979-703Dexlansoprazoledexlansoprazole
    24979-704Dexlansoprazoledexlansoprazole
    49884-148DexlansoprazoleDexlansoprazole
    50090-5944Dexlansoprazoledexlansoprazole
    50090-5956Dexlansoprazoledexlansoprazole

    Trademark Results [Dexilant]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DEXILANT
    DEXILANT
    77946349 3887990 Live/Registered
    TAKEDA PHARMACEUTICALS U.S.A., INC.
    2010-02-26
    DEXILANT
    DEXILANT
    77946331 3887989 Live/Registered
    TAKEDA PHARMACEUTICALS U.S.A., INC.
    2010-02-26
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.